Scott Bernstein, a drug policy and human rights lawyer and the Executive Director of MAPS Canada, discusses the January 5, 2022 news-making amendment to Canadian drug laws that has direct implications for access to MDMA Assisted Therapy. Is this big news or not? What does the amendment mean? Who might be eligible for MDMA-Assisted Therapy? Is Canada leading the world? And what is the next step in the process of making MDMA-Assisted Therapy available to Canadians in need?